PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PharmAbcine Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10858
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab sequence analysis, and other services. PharmAbcine offers expression and purification for binding test and KD determination, initial consultation, and biopanning services, among others. The company’s technology platform also explores cancerous molecular marker by using cancer stem cell library. Its research and development facility offers discovery system for the human diseases such as cancer and inflammatory disorders. The company offers out-licensing of candidate therapeutics and clinical application. PharmAbcine is headquartered in Daejeon, South Korea.

PharmAbcine Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmAbcine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PharmAbcine Raises US$2 Million In Venture Financing 10
PharmAbcine Raises US$3.5 Million In Series B Financing 11
Partnerships 12
PharmAbcine Enters into Agreement with Merck 12
PharmAbcine Enters Into Research Agreement With Sanofi For Antibody Drug Discovery 13
Licensing Agreements 14
3SBio Enters into Licensing Agreement with PharmAbcine for DIG-KT 14
3SBio Enters into Licensing Agreement with PharmAbcine for Tanibirumab 15
PharmAbcine Enters into Licensing Agreement with Triphase Accelerator 16
PharmAbcine Inc – Key Competitors 17
PharmAbcine Inc – Key Employees 18
PharmAbcine Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
PharmAbcine Inc, Pharmaceuticals & Healthcare, Key Facts 2
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmAbcine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmAbcine Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PharmAbcine Raises US$2 Million In Venture Financing 10
PharmAbcine Raises US$3.5 Million In Series B Financing 11
PharmAbcine Enters into Agreement with Merck 12
PharmAbcine Enters Into Research Agreement With Sanofi For Antibody Drug Discovery 13
3SBio Enters into Licensing Agreement with PharmAbcine for DIG-KT 14
3SBio Enters into Licensing Agreement with PharmAbcine for Tanibirumab 15
PharmAbcine Enters into Licensing Agreement with Triphase Accelerator 16
PharmAbcine Inc, Key Competitors 17
PharmAbcine Inc, Key Employees 18
PharmAbcine Inc, Other Locations 19

List of Figures
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmAbcine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ketchum, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ketchum, Inc. Mergers and Acqui …
  • Korean Reinsurance Company:企業の戦略・SWOT・財務分析
    SummaryKorean Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Incitec Pivot Limited (IPL):企業の財務及び戦略的SWOT分析
    Incitec Pivot Limited (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Beijing Tianrun New Energy Investment Co., Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Beijing Tianrun New Energy Investment Co., Ltd. (Tianrun New Energy), a subsidiary of Xinjiang Goldwind Science & Technology Co., Ltd, is a renewable energy company that provides various services to wind power sector. The company offers services like consulting, planning, development, invest …
  • Allscripts Healthcare Solutions Inc (MDRX)-医療機器分野:企業M&A・提携分析
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management solutions, Population Health Manag …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    SummaryCalumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view o …
  • SNGN Romgaz S.A. (SNG):企業のM&A・提携動向(石油・ガス分野)
    Summary SNGN Romgaz S.A. (Romgaz), formerly Societatea Nationala de Gaze Naturale Romgaz SA is an oil and gas company that explores, produces, and supplies natural gas and electricity. The company provides operation of Iernut thermoelectric power station, and offers electric power supply. Its explor …
  • Capstone Mining Corp. (CS):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Capstone Mining Corp." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Global Geophysical Services, Inc.:企業の戦略的SWOT分析
    Summary Global Geophysical Services, Inc. (Global Geophysical) is an oil and gas company that provides geophysical technology for facilitating successful project execution. It offers consulting; reservoir grade 3D data sets and land and marine seismic acquisition; seismic data processing; geophysica …
  • ESSA Pharma Inc (EPI):企業財務及び戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • Ferretti S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ferretti S.p.A. Mergers and Acq …
  • Hansard Global plc:企業の戦略・SWOT・財務情報
    Hansard Global plc - Strategy, SWOT and Corporate Finance Report Summary Hansard Global plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medtech Global Ltd (MDG):企業財務及び戦略的SWOT分析
    Summary Medtech Global Ltd (Medtech) is a healthcare technology company that offers software solutions for healthcare environment. The company’s products comprise primary health, secondary health, personal and telehealth, data intelligence and data mobility. Its services include customer care, data …
  • Faith, Inc. (4295):企業財務及び戦略的SWOT分析
    Summary Faith, Inc. (Faith) is a technology service provider that offers solutions from music and video production and distribution system construction. The company offers services in the areas of music communication, entertainment communication, educational communication and life communication. It …
  • NEOTIONの企業概要及び財務/SWOT分析
    NEOTION Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts mad …
  • EMCOR Group, Inc.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "EMCOR Group, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務分析
    SummaryMarina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Great Bear Resources Ltd. (GBR):企業財務及び戦略的SWOT分析
    Summary Great Bear Resources Ltd. (GBRL) formerly Great Bear Uranium Corp. is a nuclear energy company that offers exploration and development services. The company acquires and explores mineral properties such as uranium and other metals. It explores for metals such as gold, silver, and other ores. …
  • Adhezion Biomedical, LLC:企業のM&A・提携動向(医療機器分野)
    Summary Adhezion Biomedical, LLC (Adhezion) is a medical device company that develops, manufactures and commercializes cyanoacrylate based surgical, wound management and infection prevention technologies. Its product portfolio includes professional products such as surgical, wound management, and in …
  • BRS Aerospace:企業の戦略・SWOT・財務情報
    BRS Aerospace - Strategy, SWOT and Corporate Finance Report Summary BRS Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆